$2.17
+0.00 (+0.00%)
Open$2.15
Previous Close$2.17
Day High$2.18
Day Low$2.08
52W High$12.37
52W Low$1.81
Volume—
Avg Volume53.9K
Market Cap17.56M
P/E Ratio—
EPS$-1.96
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+794.5% upside
Current
$2.17
$2.17
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.94M | 1.86M | 22.16M |
| Net Income | -14,298,259 | -8,138,396 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -15,312,223 | -9,199,729 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |